Pricing Log in Create free account

Novogen Limited (KZIA) vs Neumora Therapeutics, Inc. (NMRA)

Novogen Limited and Neumora Therapeutics, Inc. are both Biotechnology companies. Novogen Limited and Neumora Therapeutics, Inc. are of similar size ($84.6M and $80.2M). Across the 8 metrics below, Novogen Limited leads on 7 and Neumora Therapeutics, Inc. on 1.

Valuation

Metric KZIA NMRA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 1.95 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.46 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (2.98%) (261.70%) (33.15%)
Free cash flow yield 0.00% (207.20%) (25.50%)

Profitability

Metric KZIA NMRA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (187.11%) (56.36%)
Return on assets 0.00% (121.89%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KZIA NMRA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 63.24% 5.23% 30.26%
Revenue growth, 5-year CAGR 11.56% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric KZIA NMRA Biotechnology median
Debt to equity 0.00 1.19 0.00
Current ratio 2.87 4.50 4.72
Net debt to EBITDA 0.30 0.53 0.96

Dividend

Metric KZIA NMRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KZIA NMRA Biotechnology median
Market cap 84.58m 80.23m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack